%0 Case Reports
%T Successful treatment of metastatic colorectal cancer with synchronous BRAF V600E mutation and dMMR with BGB-A317.
%A Cheng Y
%A Fang XF
%A Hu HG
%A Wang J
%A Sun LF
%A Yuan Y
%J Immunotherapy
%V 12
%N 4
%D 03 2020
%M 32172642
%F 4.04
%R 10.2217/imt-2019-0148
%X Metastatic colorectal cancer with BRAF mutation is a type of highly invasive malignant tumor with poor prognosis and few treatment options. Here, we report a case of a BRAF-mutant and DNA mismatch-repair deficiency colorectal cancer patient with postoperative recurrence as well as abdominal cavity and pelvic metastasis, whose condition was relieved continuously after treatment with a new anti-PD-1 antibody, BGB-A317.